TenderlineUK
Procurement Intelligence
Official OCDSSearch

Retender radar: UK public contracts ending soon

Every contract on Find a Tender with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting — unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.

Contracts ending in the next 12 months

Page 18 · 100 contracts on this page · more available

SortEnding soonestLargest contract valueLargest annual run-rate
FrameworkClear all

1,000+ contracts

  1. Ends · in 230 daysFramework re-letPanel · 2 suppliers

    NRW Timber signs and structures 2023-2027

    Natural Resources Wales · Wales (Cymru)

    Panel: Signs Workshop Limited, The Creative Core Group Ltd

    • Signage
    • Timber
    • Woodwork
    Contract value
    £750kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-03b676
  2. Ends · in 230 daysFramework re-let

    The Provision of Auction Services for Vehicles, Plant and Machinery Equipment

    Leeds City Council · Local authority · Yorkshire and the Humber

    Incumbent: Commercial Vehicle Auctions Limited

    • Auction services
    Contract value
    £640kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-03abc1
  3. Ends · in 230 daysFramework re-letPanel · 4 suppliers

    Contract

    the Education Authority · Education · Northern Ireland

    Panel: Charles Hughes Ltd., Healthy Bean Ltd, KELTIC LIMITED +1 more

    • Caps
    • Chin straps for headgear
    • Clothing accessories
    Contract value
    £500kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c92a
  4. Ends · in 230 daysFramework re-let

    Tender for Resettlement, Asylum and Refugee Support

    Sandwell Metropolitan Borough Council · Local authority · West Midlands

    Incumbent: Afghanistan and Central Asian Association (ACCA)

    • Health and social work services
    Contract value
    £415kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-0448d6
  5. Ends · in 230 daysFramework re-letExtension option · up to 31 May 2030Buyer plans to re-tender 1 Jul 2030

    Contract for the provision of daily and deep cleaning at Quadrant Bus Station

    City & County of Swansea · Local authority · Wales (Cymru)

    Incumbent: APT ICC LTD

    • Accommodation, building and window cleaning services
    • Cleaning services
    Contract value
    £297kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    1 Jun 2026 → 31 May 2027 · 11 months · up to 31 May 2030 with extensions
    Reference
    ocds-h6vhtk-05a43b
  6. Ends · in 230 daysFramework re-let

    Supply and Installation of Burial Chambers

    Sandwell Metropolitan Borough Council · Local authority · West Midlands

    Incumbent: Gem Precast

    • Cemetery services
    • Cemetery works
    Contract value
    £268kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-03c448
  7. Ends · in 230 daysFramework re-let

    Waste composition analysis of separate flexibles collections from purpose-built flats

    London Waste and Recycling Board operating as ReLondon · Other public body · Nationwide (UK), North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands

    Incumbent: RECYCLING OF USED PLASTICS LIMITED

    • Composition services
    Contract value
    £62kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    1 Sept 2026 → 31 May 2027 · 8 months
    Reference
    ocds-h6vhtk-06c08b
  8. Ends · in 230 daysFramework re-let

    BT Connectivity Legacy PSTN Lines

    The Police and Crime Commissioner for Surrey · Police & fire · Nationwide (UK)

    Incumbent: BT PLC Services

    Contract value
    £60kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    11 Jun 2026 → 31 May 2027 · 11 months
    Reference
    ocds-h6vhtk-06b2c0
  9. Ends · in 230 daysFramework re-let

    BT Connectivity - Legacy PSTN Lines

    The Police & Crime Commissioner for Sussex · Police & fire · Nationwide (UK)

    Incumbent: BT PLC Services

    Contract value
    £60kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    12 Jun 2026 → 31 May 2027 · 11 months
    Reference
    ocds-h6vhtk-06b2ea
  10. Ends · in 230 daysFramework re-letExtension option · up to 31 May 2030Buyer plans to re-tender 1 Jul 2030Panel · 5 suppliers

    Framework for the Provision of Corporate Cleaning Services Framework Reference: CCS/25/230 – Lot 1

    City & County of Swansea · Local authority · Wales (Cymru)

    Panel: 1ST CHOICE PRO CLEANING SERVICES LTD, BELL CLEANING SERVICES LTD, Cleaning Solutions +2 more

    • Accommodation, building and window cleaning services
    • Cleaning services
    Contract value
    £23kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Jun 2026 → 31 May 2027 · 11 months · up to 31 May 2030 with extensions
    Reference
    ocds-h6vhtk-05a43b
  11. Ends · in 230 daysFramework re-letExtension option · up to 31 May 2030Buyer plans to re-tender 1 Jul 2030

    Framework for the Provision of Corporate Cleaning Services – Lot 4: Window Cleaning at Swansea Bus Station

    City & County of Swansea · Local authority · Wales (Cymru)

    Incumbent: CDC Specialists Ltd

    • Accommodation, building and window cleaning services
    • Cleaning services
    Contract value
    £18kceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    1 Jun 2026 → 31 May 2027 · 11 months · up to 31 May 2030 with extensions
    Reference
    ocds-h6vhtk-05a43b
  12. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Milpharm Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  13. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Roma Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  14. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Perennial Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  15. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Consilient Health Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  16. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  17. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Rosemont Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  18. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: GLAXOSMITHKLINE UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  19. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aventis Pharma Ltd Trading As Sanofi

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  20. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Sandoz

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  21. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Flynn Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  22. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Dr Reddy's Laboratories (UK) Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  23. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Kent Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  24. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Glenmark Pharmaceuticals Europe Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  25. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Esteve Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  26. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Healthcare Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  27. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Ranbaxy (UK) Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  28. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: CST Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  29. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Teva UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  30. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Gerot Lannach UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  31. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Alissa Healthcare Research Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  32. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Day Lewis Medical Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  33. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Morningside Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  34. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Selective Supplies Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  35. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: ennogen healthcare ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  36. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Venture Healthcare Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  37. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: medac Pharma LLP

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  38. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Mercury Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  39. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Thornton and Ross Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  40. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Organon Pharma (UK) Ltd.

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  41. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Janssen-Cilag Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  42. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Amarox Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  43. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Colonis Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  44. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Neuraxpharm UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  45. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Novumgen Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  46. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Tillotts Pharma UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  47. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Abbvie Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  48. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aspire Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  49. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: ACCORD-UK LTD

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  50. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Neon Healthcare

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  51. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Bristol Laboratories

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  52. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Syri Limited (T/A Thame Laboratories)

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  53. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Arcadia Pharma Ltd T/A Arcadia Medical

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  54. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Kyowa Kirin Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  55. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Waymade PLC

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  56. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Medreich PLC

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  57. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Dr Falk Pharma UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  58. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Lupin Healthcare UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  59. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Crescent Pharma Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  60. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Derma UK

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  61. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Strides Pharma Uk LTD

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  62. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Phoenix Lab

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  63. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: DRUGSRUS LTD

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  64. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aspen Pharmacare UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  65. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Scope Ophthalmics Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  66. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: AOP Orphan Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  67. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Martindale Pharma

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  68. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Bayer Plc

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  69. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Krka UK ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  70. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Relonchem Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  71. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Ferring Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  72. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Torrent Pharma UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  73. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: JCSH Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  74. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Lundbeck Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  75. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  76. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Reckitt Benckiser

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  77. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Strandhaven Ltd t/a Somex Pharma

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  78. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Wockhardt UK Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  79. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Synchrony Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  80. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Brown and Burk UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  81. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Tillomed Laboratories Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  82. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Galen Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  83. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Necessity Supplies Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  84. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Medley Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  85. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Manx Healthcare Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  86. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: LogixX Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  87. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Ascend Laboratories UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  88. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Rivopharm UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  89. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Zentiva Pharma UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  90. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Norgine Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  91. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Cipla

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  92. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Genesis Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  93. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Focus Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  94. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Beaumont Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  95. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Typharm Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  96. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Oralieve UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  97. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Clydesdale Pharma ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  98. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: RPH Pharmaceuticals AB

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  99. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Uni Health Distribution Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  100. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Ipca Laboratories UK Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
How to read the radar
  • End date is the contract period end the buyer published on Find a Tender. Contracts without an end date are not on the radar.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
  • Incumbent is the canonical supplier on the award behind the contract. A panel (several suppliers on one award) is shown as a panel — no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
  • Counts are exact from the nightly projection when you filter by horizon and sector only; any other filter shows a bounded total — exact up to 1,000 contracts, an honest “1,000+” floor above that.